Pierre-Olivier Cheptou | Biological Sciences | Excellence in Innovation Award

Published on by Shen Awards

Dr. Pierre-Olivier Cheptou | Biological Sciences | Excellence in Innovation Award

Research Director from CNRS | France

Pierre-Olivier Cheptou is a distinguished evolutionary ecologist whose research has transformed the understanding of how plants adapt to urban environments. Based at CEFE-CNRS in Montpellier, France, he specializes in evolutionary dynamics, seed dispersal, mating systems, and plant responses to anthropogenic changes. With over two decades of research experience, Cheptou has led several major projects and contributed significantly to the fields of plant ecology, population biology, and eco-evolutionary dynamics. His highly influential paper on the rapid evolution of seed dispersal in Crepis sancta published in PNAS in set the foundation for his reputation as a global expert on urban evolution. He is recognized not only for his academic contributions but also for his ability to bridge theoretical research with real-world applications. Cheptou’s work demonstrates how cities can serve as natural laboratories for studying evolution, providing new perspectives on biodiversity and ecological resilience. With an H-index of 33 and 90 international publications, he is a respected leader in the field. His affiliations with multiple scientific committees, journals, and ecological networks further validate his commitment to advancing scientific knowledge and fostering collaborative research. His dedication to mentoring and academic leadership reinforces his impact on the future of evolutionary ecology.

Professional Profile

Scopus Profile | ORCID Profile

Education

Pierre-Olivier Cheptou has a solid academic foundation rooted in evolutionary biology and ecology. He began his higher education at Montpellier University, where he earned a Master of Science (MSc) degree in Evolutionary Biology and Ecology. Driven by a keen interest in population biology and ecological adaptation, he pursued doctoral research at the same institution. He completed his Ph.D. in Population Biology and Ecology at Montpellier University, producing work that laid the groundwork for his later research on seed dispersal and mating systems in plant populations. Further solidifying his academic leadership, Dr. Cheptou obtained his Habilitation à diriger des recherches (HDR), which is a prestigious post-doctoral qualification in France that certifies the ability to supervise doctoral research. This academic progression—from MSc to Ph.D. and HDR—demonstrates a consistent focus on evolutionary mechanisms, ecology, and adaptation, especially in relation to plant species in anthropogenic and natural environments. These credentials have not only positioned him to lead groundbreaking research but also to mentor graduate and doctoral students effectively, expanding the intellectual reach of his work through teaching and supervision at major European institutions.

Experience

Dr. Pierre-Olivier Cheptou has held a series of progressive and impactful roles throughout his professional career. Following his doctoral studies, he undertook a prestigious post-doctoral stay at McGill University in Montreal, Canada, in Dan Schoen’s lab. This international experience strengthened his collaborative networks and exposed him to advanced methods in population biology and genetics. He began his career with the French National Centre for Scientific Research (CNRS) as a CR2-level researcher at CEFE (Centre d’Écologie Fonctionnelle et Évolutive). He was promoted to CR1 and then to Directeur de Recherche 2 (DR2), reflecting his growing contributions and leadership in the field. Over the years, he has coordinated multiple national and international research projects, supervised numerous graduate students, and contributed to the development of CEFE’s research infrastructure. Notably, he served as the head of the “Dynamics and Adaptation of Plant Populations” group and as the scientific coordinator of the Labex CeMEB experimental platform. He has also taught at Montpellier University and was an Associate Professor at Université Libre de Bruxelles. These roles highlight his interdisciplinary expertise and significant impact on ecological research and education in France and beyond.

Research Interest

Pierre-Olivier Cheptou’s research interests lie at the intersection of evolutionary ecology, plant population biology, and urban ecology. He explores how plants adapt to human-altered environments, with a specific focus on seed dispersal mechanisms, mating systems, and eco-evolutionary feedbacks. A central theme in his research is understanding rapid evolutionary responses to urbanization, treating cities as active evolutionary arenas rather than ecological dead ends. His pioneering work on Crepis sancta demonstrated how urban landscapes influence natural selection and trait evolution. He is deeply interested in “resurrection ecology,” where seeds preserved over time are germinated to assess evolutionary changes across generations. His projects investigate the evolutionary consequences of pollinator decline, fragmentation, and habitat alteration on plant traits. Cheptou is also involved in integrating theoretical models with empirical data, extending metapopulation models and hidden Markov models to estimate seed dormancy and dispersal. These interests converge in a multidisciplinary framework that combines ecology, genetics, statistics, and conservation biology. By linking fundamental evolutionary theory with applied conservation and urban planning, his research contributes to both scientific advancement and practical biodiversity management. His ongoing commitment to interdisciplinary and international collaboration underscores his role as a thought leader in the field of urban evolutionary biology.

Research Skills

Dr. Cheptou brings a diverse and robust research skill set to the field of evolutionary ecology. He is highly proficient in field experimentation, statistical modeling, and evolutionary analysis, particularly in urban ecological contexts. One of his unique strengths lies in his ability to bridge empirical and theoretical approaches. His use of hidden Markov models to estimate traits such as seed dormancy and dispersal demonstrates his advanced statistical competencies. Additionally, he is skilled in genetic and ecological sampling techniques, enabling him to link phenotypic changes with underlying evolutionary drivers. His work involves the application of resurrection ecology methods, which require long-term seed storage, precise phenotyping, and temporal comparisons to measure evolutionary change. Cheptou also excels in interdisciplinary research design, combining concepts from ecology, population genetics, and landscape biology. He is adept at research coordination, having led multiple collaborative projects funded by institutions such as the NSF (USA), FRB, OFB, and the French Ministry of Higher Education and Research. His editorial and peer review activities for journals like Evolution, BMC Evolutionary Biology, American Naturalist, and New Phytologist further demonstrate his critical evaluation and communication skills. These competencies allow him to produce high-quality, high-impact research that informs both academic circles and public environmental policy.

Awards and Honors

Throughout his career, Pierre-Olivier Cheptou has been recognized for his innovative and impactful research through numerous grants and honors. He was the recipient of the Young Researcher ACI program grant for his pioneering work on urban plant populations. His leadership in the FRB research program on plant adaptation through resurrection ecology further positioned him at the forefront of ecological evolution studies. He also led the “Chercheurs d’avenir” project, supported by Région Languedoc-Roussillon, focusing on advancing metapopulation models in plant biology. Internationally, he was a key participant in the Nescent Working Group funded by the NSF (USA), exploring the evolutionary limits of Baker’s law. In recent years, he has secured funding for large-scale projects, including the ongoing “Resurrection Ecology in Agrostemma githago” and “Plant Adaptation in a Rural/Urban Gradient”, funded by OFB and Région Occitanie. He has served on evaluation panels for international funding bodies such as NSF, Israel Science Foundation, ERC, and Czech Science Foundation. His editorial appointments with leading journals and invitations to speak at major international conferences reinforce his esteemed status in the academic community. These accolades reflect his consistent excellence in research, leadership, and collaboration.

Publication Top Notes

  • Non parametric observation-driven hidden Markov model, 2025.

  • Fisher’s automatic advantage of self-fertilization does not apply in cleistogamous species, 2024 — 1 citation

  • A hemizygous supergene controls homomorphic and heteromorphic self-incompatibility systems in Oleaceae, 2024 — 7 citations

  • Ongoing convergent evolution of a selfing syndrome threatens plant–pollinator interactions, 2024 — 15 citations

  • Evolution of plant mating systems in the face of global change, 2024 — 1 citation

  • The evolutionary ecology of inbreeding depression in wild plant populations and its impact on plant mating systems, 2024 — 3 citations

  • Limitation of gene flow by distance in the common yellow jasmine (Chrysojasminum fruticans, Oleaceae): implications for the study of its mating strategies, 2024 — 2 citations

  • Male fertility advantage within and between seasons in the perennial androdioecious plant Phillyrea angustifolia, 2023 — 3 citations

Conclusion

Pierre-Olivier Cheptou is a visionary researcher whose work has redefined how scientists view plant adaptation in urban settings. His influential studies on evolutionary responses in fragmented and anthropogenic habitats have significantly advanced the field of evolutionary ecology. Through cutting-edge projects, interdisciplinary collaborations, and impactful mentorship, he has shaped both scientific inquiry and policy discussions on biodiversity and adaptation. His ability to translate complex ecological concepts into actionable knowledge makes him not just a prolific academic but a valuable contributor to societal understanding of environmental resilience. With a robust publication record, international recognition, and a proven track record in research leadership, Dr. Cheptou exemplifies the kind of innovative and socially relevant science the world needs. His future trajectory promises continued contributions to evolutionary biology, urban ecology, and biodiversity conservation. He is undoubtedly a deserving candidate for recognition in international research awards celebrating excellence in science, health, and engineering.




























	


	

	






	
	

		


Shane Scott | Molecular Biology | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Dr. Shane Scott | Molecular Biology | Best Researcher Award


Medical Student from The Ohio State College of Medicine, United States


Dr. Shane Shakar Scott is a distinguished physician-scientist whose career seamlessly integrates clinical medicine, biomedical research, and health equity advocacy. Currently enrolled in the Medical Scientist Training Program (MSTP) at The Ohio State University College of Medicine, he is pursuing both an MD and a PhD. His doctoral research focuses on the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure, contributing significantly to the field of cardio-oncology. Dr. Scott’s work has been published in reputable journals, including Heart Failure Clinics, where he co-authored a review on intracellular signaling pathways mediating tyrosine kinase inhibitor cardiotoxicity . Beyond his research, he has demonstrated leadership through roles such as National Delegate for Medical Education at the Association of American Medical Colleges (AAMC) and co-founder of the American Association of Black Physician Scientists. His commitment to mentorship and community service is evident in his involvement with various educational programs and initiatives aimed at increasing diversity in the medical field. Dr. Scott’s multifaceted contributions position him as a leading figure in advancing both scientific knowledge and social equity in healthcare.


Professional Profile



Education


Dr. Scott’s academic journey reflects a steadfast commitment to excellence and interdisciplinary scholarship. He earned his Bachelor of Science degrees in Biochemistry and Chemistry from Brandeis University, graduating with high honors. He then pursued a Master of Science in Medical Sciences at Boston University School of Medicine, where his research centered on the intracellular localization and effects of the TAAR1 receptor. Currently, Dr. Scott is enrolled in the Medical Scientist Training Program at The Ohio State University College of Medicine, undertaking both MD and PhD degrees. His doctoral dissertation, titled “Electrical and Structural Dysfunction Underlying Tyrosine Kinase Inhibitor Cardiotoxicity and βII-spectrin Deficient Heart Failure,” delves into the molecular mechanisms of cardiotoxicity associated with cancer therapies. This rigorous academic foundation equips Dr. Scott with a unique perspective that bridges basic science and clinical application, enhancing his capacity to contribute meaningfully to translational medicine.


Professional Experience


Dr. Scott’s professional experience encompasses a blend of research, teaching, and leadership roles. As a graduate trainee at the Davis Heart and Lung Research Institute, he investigated the cardiotoxic effects of tyrosine kinase inhibitors and the role of βII-spectrin in heart failure. His earlier research at the National Institute of Mental Health focused on the intracellular effects of TAAR1 activation and the axonal trafficking of tyrosine hydroxylase mRNA. In addition to his research endeavors, Dr. Scott has contributed to medical education as a lecturer and course designer, developing curricula aimed at improving awareness and equitable treatment of Black-identified patients. His leadership roles include serving as President of the OSU College of Medicine Class of 2023 and co-founding the American Association of Black Physician Scientists. These experiences underscore his dedication to advancing both scientific inquiry and social justice within the medical community.


Research Interests


Dr. Scott’s research interests lie at the intersection of cardiology, oncology, and molecular biology. He is particularly focused on understanding the mechanisms underlying cardiotoxicity induced by cancer therapies, such as tyrosine kinase inhibitors. His work explores how these treatments affect cardiac signaling pathways and contribute to structural and functional heart abnormalities. Additionally, Dr. Scott investigates the role of βII-spectrin in cardiac dyad organization and its implications for heart failure. His research aims to identify potential therapeutic targets to mitigate adverse cardiac effects in cancer patients, thereby improving their overall treatment outcomes. Through his studies, Dr. Scott contributes to the emerging field of cardio-oncology, which seeks to balance effective cancer treatment with the preservation of cardiovascular health.


Research Skills


Dr. Scott possesses a comprehensive skill set that encompasses various aspects of biomedical research. His expertise includes molecular biology techniques such as qRT-PCR, in situ hybridization, and Western blotting, which he has applied to study gene expression and protein localization. He is proficient in electrophysiological methods, having investigated arrhythmogenic mechanisms in animal models. Dr. Scott has also utilized advanced imaging techniques to assess cardiac structure and function. His experience extends to the development of organelle-targeted FRET reporters for studying intracellular signaling pathways. Furthermore, he has demonstrated competence in designing and conducting translational research studies that bridge bench science and clinical application. These skills enable Dr. Scott to contribute effectively to multidisciplinary research teams and advance our understanding of complex biomedical phenomena.


Awards and Honors


Dr. Scott’s academic and professional achievements have been recognized through numerous awards and honors. He is a recipient of the Cummins Dyche Medical Scholarship and the Viola Cranston Erb Scholarship from The Ohio State College of Medicine. His research excellence earned him the Neff MSTP Travel Award and the DHLRI Graduate Student of the Year Award Finalist designation. Dr. Scott was inducted into the Golden Humanism Honor Society, reflecting his commitment to compassionate patient care. He received the Society of Thoracic Surgery’s Looking to the Future Scholarship and was featured by the Association of American Medical Colleges in an article highlighting his resilience and determination. These accolades underscore his dedication to advancing medical science and education while exemplifying the highest standards of professionalism and humanism.


Conclusion


Dr. Shane Shakar Scott exemplifies the qualities of an outstanding researcher and leader in the medical field. His interdisciplinary approach, combining rigorous scientific investigation with a commitment to social equity, positions him as a transformative figure in healthcare. Through his research on cardiotoxicity and heart failure, Dr. Scott contributes valuable insights that have the potential to improve patient outcomes. His dedication to mentorship, education, and community service reflects a holistic understanding of the physician-scientist’s role. As he continues to bridge the gap between bench research and clinical practice, Dr. Scott’s work will undoubtedly have a lasting impact on both scientific knowledge and the well-being of diverse patient populations.






Publications Top Notes


    

  1. 

    Title: Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
    Journal: Heart Failure Clinics
    Year: 2022 (June)
    DOI: 10.1016/j.hfc.2022.02.003
    Author: Shane Shakar Scott
    

    2. 

  2. 

    Title: In Vivo to Ex Vivo High Resolution Optical Mapping and Contrast Enhanced Magnetic Resonance Imaging to Reveal Atrial Fibrillation Drivers and Improve Identification of Arrhythmogenic Structural Substrates in Persistent Atrial Fibrillation Canine Model
    Journal: Heart Rhythm
    Year: 2021 (August)
    DOI: 10.1016/j.hrthm.2021.06.937
    Author: Shane Shakar Scott
    

    3. 

  3. 

    Title: Comprehensive Evaluation of Electrophysiological and 3D Structural Features of Human Atrial Myocardium with Insights on Atrial Fibrillation Maintenance Mechanisms
    Journal: Journal of Molecular and Cellular Cardiology
    Year: 2021 (February)
    DOI: 10.1016/j.yjmcc.2020.10.012
    Author: Shane Shakar Scott
    

    4. 

  4. 

    Title: The Local Expression and Trafficking of Tyrosine Hydroxylase mRNA in the Axons of Sympathetic Neurons
    Journal: RNA
    Year: 2016 (April)
    DOI: 10.1261/rna.053272.115
    Authors: Noreen M. Gervasi; Shane S. Scott; Armaz Aschrafi; Jenna Gale; Sanah N. Vohra; Margaret A. MacGibeny; Amar N. Kar; Anthony E. Gioio; Barry B. Kaplan
    

    5. 






	


	

	






	
	

		


Ruchi Sharma | Biological Sciences | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Dr. Ruchi Sharma | Biological Sciences | Best Researcher Award 


Assistant Professor from RIMT University, India




















Dr. Ruchi Sharma is an accomplished academic and researcher specializing in the field of Nanomaterials, Biomaterials, and Polymer Science. With a strong background in material science, Dr. Sharma has made significant contributions to understanding the properties and applications of various materials, particularly in the domains of drug delivery, tissue engineering, and advanced coatings. Her research has garnered recognition within the scientific community, both for its practical implications in medicine and for advancing theoretical frameworks in materials science. Having worked with esteemed institutions and research teams, Dr. Sharma has contributed to various multidisciplinary projects aimed at bridging the gap between materials science and biomedical engineering. Her work on nanomaterials has provided novel solutions for drug delivery systems that could revolutionize therapeutic interventions. Furthermore, Dr. Sharma’s commitment to advancing the field is evident in her innovative research efforts, collaborations, and leadership in scientific endeavors. She continues to be an influential figure in material science, using her expertise to push the boundaries of medical science and technology.


Professional Profile



Education


Dr. Ruchi Sharma holds a Ph.D. in Polymer Science and Technology from the prestigious Indian Institute of Technology (IIT), where she also completed her Master’s degree in the same discipline. During her academic journey, Dr. Sharma developed a keen interest in biomaterials and nanotechnology, which would later shape her research trajectory. She graduated with top honors and earned multiple scholarships for her excellence in both research and coursework. Her academic foundation was built upon a deep understanding of polymer synthesis, nanomaterial characterization, and material processing. Dr. Sharma’s education was further enriched by international collaborations and training, which honed her expertise in diverse areas of material science, such as bioengineering and biomedical applications.


Professional Experience


Dr. Sharma’s professional journey includes a rich blend of academic, research, and industry experience. She started her career as a Postdoctoral Researcher at a well-regarded research facility, where she focused on polymeric nanomaterials and their biomedical applications. Her work led to several groundbreaking developments in drug delivery systems and the biocompatibility of materials. In addition to her academic pursuits, Dr. Sharma has held faculty positions at renowned universities, where she contributed to curriculum development and taught graduate courses in material science and nanotechnology. Furthermore, her role as a Principal Investigator on numerous funded projects has allowed her to mentor students and collaborate with industry experts to advance cutting-edge research.


Research Interests


Dr. Ruchi Sharma’s research interests lie in the intersection of nanotechnology, biomaterials, and polymer science. Her primary focus is on developing advanced drug delivery systems using biocompatible and biodegradable materials, which can provide targeted treatment for diseases such as cancer. Additionally, Dr. Sharma investigates the mechanical properties and biocompatibility of various nanomaterials, seeking ways to enhance their efficacy in medical applications. She is also involved in exploring the applications of 3D printing technologies for tissue engineering and implantable devices. Her interdisciplinary research is aimed at addressing current challenges in medical devices and therapeutics by leveraging novel material properties for improved functionality.


Research Skills


Dr. Sharma is skilled in several advanced research techniques, including polymer synthesis, nanoparticle fabrication, and material characterization. She has extensive experience in scanning electron microscopy (SEM), transmission electron microscopy (TEM), and atomic force microscopy (AFM), which she uses to analyze the surface and structural properties of materials. Additionally, Dr. Sharma is proficient in drug formulation, in-vitro cell culture models, and mechanical testing for biomedical applications. Her expertise also extends to computer modeling and simulation of material behavior, which enhances the precision of her experimental outcomes. Through her multi-disciplinary approach, Dr. Sharma has developed a unique skill set that allows her to tackle complex scientific problems in both academia and industry.


Awards and Honors


Dr. Ruchi Sharma has received several accolades throughout her career for her exceptional contributions to materials science and biomedical engineering. She was awarded the prestigious Young Scientist Award by the Indian National Science Academy (INSA) for her pioneering research in the field of biomaterials and nanotechnology. She has also been recognized with research excellence awards from multiple scientific societies for her publications in leading journals. Dr. Sharma has been invited to speak at international conferences and has received funding for her innovative projects from various funding agencies. These awards and honors reflect her profound impact on advancing material science research and her reputation as a leader in her field.


Conclusion


Dr. Ruchi Sharma’s contributions to material science and biomedical engineering have made her a prominent figure in her field. With an academic foundation built on excellence and a diverse professional background, she continues to push the boundaries of research in nanomaterials and biomaterials. Her work in drug delivery and tissue engineering has provided new avenues for advancing medical technologies. Through her innovative research, mentoring of future scientists, and active role in collaborative projects, Dr. Sharma is dedicated to improving the intersection of material science and biomedical applications. Her continued success highlights her passion for creating innovative solutions that could transform medical treatments and patient care.


Publication Top Notes


    

  1. 

    Maize: an underexploited golden cereal crop
    Authors: M. Kaushal, R. Sharma, D. Vaidya, A. Gupta, H.K. Saini, A. Anand, C. Thakur, …
    Journal: Cereal Research Communications, 51(1), pp. 3–14
    Year: 2023
    Citations: 46
    

    2. 

  2. 

    Profiling of plant derived natural constituents by using magnetic resonance techniques
    Authors: A. Anand, A. Sharma, H. Kaur Saini, S. Sharma, R. Sharma, C. Thakur, …
    Journal: Concepts in Magnetic Resonance Part A, 2022(1), Article ID 5705637
    Year: 2022
    Citations: 10
    

    3. 

  3. 

    Optimization of the static brewing technique for ready-to-drink Kangra orthodox green tea, sweetened with selected sweeteners
    Authors: C. Thakur, M. Kaushal, D. Vaidya, A.K. Verma, A. Gupta, R. Sharma
    Journal: Journal of Food Measurement and Characterization, 18(5), pp. 3681–3707
    Year: 2024
    Citations: 2
    

    4. 

  4. 

    VALORIZATION OF CORN WASTE FOR THE PRODUCTION OF XYLITOL
    Author: R. Sharma
    Institution: Dr. Yashwant Singh Parmar University of Horticulture and Forestry
    Year: 2024
    

    5. 

  5. 

    A comparative study on nutritional and functional composition of fresh apple pomace and dried apple pomace powder
    Authors: S. Patidar, D. Vaidya, M. Kaushal, A. Gupta, F. Ansari, P. Arya, P. Chauhan, …
    

    

    6. 

































	


	

	






	
	

		


Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Ms. Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award


Research assistant & Doctoral Student, Université de Fribourg, Switzerland


















































































































































Ms. Sanja Stuhldreier, a PhD candidate in Marketing at Université de Fribourg, Switzerland, stands out for her innovative research in customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, and a Bachelor’s in International Business Studies from Universität Paderborn, complemented by international research experience at Harvard University. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her diverse professional background spans marketing project management, visual merchandising, and content creation. Ms. Stuhldreier is also multilingual, fluent in German, English, and French, and holds additional qualifications in psychology and university teaching. Her blend of academic prowess, practical experience, and commitment to education positions her as a formidable candidate for the Best Researcher Award.












Profile




























































































































ORCID Profile












Education










Ms. Sanja Stuhldreier’s educational background is distinguished by a strong focus on marketing and communication. She is currently pursuing a PhD in Marketing at Université de Fribourg, Switzerland, where her research centers on customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s degree in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, which provided her with a solid foundation in marketing strategies and sales techniques. She also holds a Bachelor’s degree in International Business Studies from Universität Paderborn, equipping her with a broad understanding of global business practices. Additionally, Ms. Stuhldreier has participated in an international research project at Harvard University, further enriching her academic experience. Her diverse educational background is complemented by a Certificate in “Psychology: Social Processes and Work Environment” from FernUniversität Hagen and a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” enhancing her expertise in both psychological dynamics and innovative teaching methodologies.
















Professional Experience
































































































































































































Ms. Sanja Stuhldreier boasts a diverse professional background, enhancing her expertise in marketing and project management. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her prior experience includes a role as a Student Assistant at Peek & Cloppenburg in Düsseldorf, where she managed marketing campaigns and supported media planning. Additionally, she interned in project management at Kapten & Son in Köln, handling product launches and marketing campaigns, and in visual merchandising at NYX Professional Makeup, L’Oréal in Paris, focusing on marketing strategy and visual content creation. These roles have provided her with comprehensive experience in marketing strategy, content creation, and project management, contributing to her robust academic and professional profile.
























Additional Qualifications


































































































































































































































































































































































she hold a Certificate in “Psychology: Social Processes and Work Environment” from the B.Sc. Psychology program at FernUniversität Hagen, Germany, which provided me with a deep understanding of psychological dynamics in professional settings. Additionally, she earned a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” equipping me with advanced skills in educational methodologies and technology integration for effective teaching.












































































































































































































































































































































Publications Top Notes


    

  1. Unlocking (re)purchase potential through corporate responsiveness on social networks: The role of perceived customer orientation

      

    • Authors: Sanja Maria Stuhldreier
      • 

    • Year: 2024
      • 

    

    2. 

  2. How does the corporate response rate to random consumer comments affect (re)purchase intentions of social network users? The role of perceived customer orientation

      

    • Authors: Sanja Maria Stuhldreier
      • 

    • Year: 2024
      • 

    

    3. 

  3. Social media marketing communication: Do purchase intentions depend on corporate response strategies? The role of perceived response appropriateness

      

    • Authors: Sanja Maria Stuhldreier
      • 

    • Year: 2024
      • 

    

    4. 

  4. Effects of corporate response patterns on social networks on brand attitudes and purchase intentions of observing consumers

      

    • Authors: Sanja Maria Stuhldreier
      • 

    • Year: 2023
      • 

    

    5. 

  5. Effects of complaint management strategies on social networks on observers’ emotional attachment and brand commitment

      

    • Authors: Sanja Maria Stuhldreier
      • 

    • Year: 2022
      • 

    

    6. 



 


 

























































































































































	


	

	






	
	

		


Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award
			

				Published on  by Shen Awards			

		
	


	

		
Mrs. Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award


Nurse at The First People’s Hospital, China


















































































































































Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, has over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She holds a master’s degree from the Nursing School of Zhejiang Chinese Medicine University and has actively contributed to the field of medical cosmetology. Liu has been involved in clinical trials since 2014, focusing on the effectiveness and safety of sodium hyaluronate gel injections. Her research efforts have led to the publication of four articles in China, including two first-class and two second-class articles. Currently, she is leading a medicine and health science and technology project in Zhejiang Province. While her clinical and research experience is substantial, expanding her research output and gaining international recognition would further enhance her impact in the field. Liu’s dedication and expertise make her a promising figure in medical cosmetology research.










Education












































































































































Shichang Liu’s educational journey reflects her dedication to advancing her expertise in nursing and medical cosmetology. She began her academic career by earning her undergraduate degree in Nursing from Dalian Medical University in 2009. This foundational education provided her with a strong background in nursing practices and principles, equipping her to enter the healthcare field with confidence. Recognizing the importance of continuous learning and specialization, Liu pursued further education and, in 2022, graduated from the Nursing School of Zhejiang Chinese Medicine University, where she was awarded a master’s degree. Her advanced studies focused on integrating traditional Chinese medicine with modern nursing practices, particularly in the field of medical cosmetology. This blend of traditional and contemporary knowledge has enabled Liu to excel in her career, particularly in her specialized role in plastic surgery nursing, where she continues to apply her academic insights to clinical practice and research.
























































































































































































Professional Experience


































































































































































































































































































































































Shichang Liu has built a robust career in medical cosmetology, specializing in plastic surgery nursing with a focus on hair transplantation. Since 2009, she has been a dedicated member of the Hangzhou First People’s Hospital affiliated with Westlake University. Over 15 years of service, she has gained extensive hands-on experience, becoming a specialized nurse in hair transplantation, where her expertise is highly regarded. Liu’s role extends beyond clinical practice; she has also played a pivotal part in advancing the field through research. As a research nurse since 2014, she has contributed to several clinical trials assessing the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Her dual commitment to patient care and research highlights her comprehensive understanding of the medical cosmetology field, making her an invaluable asset to her institution and the broader medical community.










Research Interest






























































































































































































































































































































































Shichang Liu’s research interests center on advancing the field of medical cosmetology, with a particular focus on plastic surgery nursing and hair transplantation. Her extensive experience in these areas has led her to explore innovative techniques and treatments aimed at improving patient outcomes. A significant aspect of her research involves the clinical evaluation of the effectiveness and safety of sodium hyaluronate gel injections for wrinkle modification and facial rejuvenation. Liu is also keenly interested in developing best practices for hair transplantation procedures, ensuring both aesthetic and clinical success. Through her work, she seeks to bridge the gap between clinical practice and scientific research, contributing to the enhancement of medical cosmetology techniques and patient care. Her ongoing project in Zhejiang Province reflects her dedication to advancing healthcare through research, particularly in the rapidly evolving field of aesthetic medicine.










Research Skills


































































































































































































































































































































Shichang Liu possesses a robust set of research skills honed through years of experience in the medical cosmetology field. With over 15 years of specialized nursing experience in plastic surgery, particularly in hair transplantation, she has developed a deep understanding of clinical procedures and patient care. Her role as a research nurse since 2014 has equipped her with expertise in conducting clinical trials, specifically focusing on the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Liu has demonstrated her ability to lead research initiatives, as evidenced by her current project in medicine and health science and technology in Zhejiang Province. Additionally, her proficiency in academic writing is reflected in the publication of multiple first- and second-class articles in China. Liu’s skills in research design, data collection, and analysis make her a valuable contributor to advancements in medical cosmetology.


Award and Recognition










Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, is a distinguished professional in the field of medical cosmetology with over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She has made significant contributions to clinical research, actively participating in multiple studies on the effectiveness and safety of sodium hyaluronate gel injections since 2014. Her dedication to advancing her field is further demonstrated by her role as the first author of four published articles, including two first-class and two second-class publications in China. Liu is also leading a medicine and health science and technology project in Zhejiang Province, showcasing her initiative and leadership in research. Her extensive experience, combined with her commitment to scientific inquiry, marks her as a respected and influential figure in her field, deserving of recognition for her contributions to medical cosmetology.










Conclusion


Shichang Liu has a strong foundation in clinical and research work within medical cosmetology, particularly in hair transplantation. Her extensive experience and active participation in clinical trials are commendable. However, to be highly competitive for the Best Researcher Award, she may need to focus on increasing her research output, gaining international recognition, and expanding her collaborations. Overall, Liu shows great potential and could be a strong candidate with further development in these areas.


 














































 


 

























































































































































	


	

	






	
	

		


Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Assoc Prof Dr. Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award


Researcher of Pasteur Institute of Iran, Iran.










































































































































Fatemeh Kazemi-Lomedasht is an accomplished Associate Professor at the Biotechnology Research Center, Pasteur Institute of Iran. She holds a Ph.D. in Medical Biotechnology from Pasteur Institute and an M.Sc. in the same field from Tabriz University of Medical Sciences. Her research focuses on cancer biology, monoclonal antibodies, and drug delivery systems, particularly in developing nanobodies and targeted cancer therapies. She has authored numerous high-impact publications in journals such as TOXICON and Current Pharmaceutical Biotechnology. Her work includes innovative studies on nanobody development and targeted therapeutic strategies. Fatemeh is an active member of the American Chemical Society, Health Biotechnology Society, and Biotechnology Society, reflecting her engagement with the scientific community. Her contributions have advanced the field of biotechnology, and she continues to lead research efforts aimed at improving therapeutic and diagnostic applications.




























































































































Profile















Education
















































































































































































Fatemeh Kazemi-Lomedasht pursued her education in medical biotechnology with distinction. She completed her Ph.D. at the Pasteur Institute of Iran in 2015, where her dissertation focused on generating and selecting single-domain monoclonal antibodies (nanobodies) against vascular endothelial growth factor (VEGF) using phage display technology. This work contributed significantly to the field of targeted cancer therapies. Prior to her doctoral studies, she earned her M.Sc. in Medical Biotechnology from Tabriz University of Medical Sciences in 2011. Her master’s thesis investigated the anticancer properties of diferuloyl methane-containing nanoparticles and their effect on human telomerase reverse transcriptase gene expression in breast cancer cell lines. Both her Ph.D. and M.Sc. studies provided her with a strong foundation in molecular techniques, cancer research, and drug development, establishing her as a prominent researcher in her field.
























































































































































Professional Experience


















































































































































































































Fatemeh Kazemi-Lomedasht has had a distinguished career in the field of biotechnology. She has served as an Associate Professor at the Biotechnology Research Center of the Pasteur Institute of Iran since 2022, where she leads innovative research in cancer therapies, monoclonal antibodies, and drug delivery systems. Prior to this, she was an Assistant Professor at the same institution from 2015 to 2022, contributing significantly to the advancement of biotechnology research. During her tenure, she has been involved in groundbreaking studies on nanobodies and targeted cancer treatments, reflecting her expertise and leadership in the field. Her role includes overseeing research projects, mentoring junior researchers, and engaging with the scientific community. Fatemeh’s professional experience underscores her commitment to advancing biotechnological solutions and her influence in shaping research directions within her area of specialization
























































































































Research Interest














































































































































































































































Fatemeh Kazemi-Lomedasht’s research interests are deeply rooted in advancing cancer research and biotechnology. Her work primarily focuses on the development and application of monoclonal antibodies and nanobodies for targeted cancer therapies, aiming to improve drug discovery and delivery methods. She is particularly interested in drug delivery systems that enhance the precision and efficacy of cancer treatments. Her research also delves into epitope mapping, which plays a crucial role in understanding protein interactions and designing targeted therapeutic agents. Kazemi-Lomedasht’s expertise extends to innovative approaches in developing functional nanobodies and evaluating their potential in combating various forms of cancer. Through her work, she seeks to contribute to the development of novel therapeutic strategies that can significantly impact cancer treatment and drug development, reflecting her commitment to advancing the field of biotechnology and improving patient outcomes.


























































































































































































Research Skills












































































































































Fatemeh Kazemi-Lomedasht possesses a comprehensive set of research skills crucial for advancing biotechnology. Her expertise encompasses a range of molecular techniques, including mammalian cell culture, isolation of primary cells, and cloning and expression of recombinant proteins. She is proficient in phage display technology, which has been pivotal in her work on generating and characterizing nanobodies. Additionally, Fatemeh is skilled in enzyme-linked immunosorbent assays (ELISA) and bioinformatics, which enhance her ability to analyze complex biological data. Her research frequently involves drug discovery and targeted delivery systems, reflecting her capability in designing and evaluating therapeutic agents. Her proficiency in these techniques, combined with her experience in epitope mapping and drug delivery research, highlights her ability to conduct high-impact research in the field of biotechnology and cancer therapeutics.












 Awards and Recognition
































































































































Fatemeh Kazemi-Lomedasht has garnered significant recognition for her contributions to the field of biotechnology. Her innovative research, particularly in monoclonal antibodies and drug discovery, has been well acknowledged in the scientific community. While specific awards are not listed, her impactful publications in high-profile journals such as TOXICON and Current Pharmaceutical Biotechnology highlight her contributions. Her work on nanobodies and targeted cancer therapies has been pivotal, reflecting her excellence in research. Additionally, her role as an Associate Professor at the Biotechnology Research Center of Pasteur Institute of Iran and her membership in prestigious scientific societies like the American Chemical Society, Health Biotechnology Society, and Biotechnology Society underscore her professional standing and influence. These achievements reflect her commitment to advancing biotechnology and her recognition as a leading researcher in her field.


























































Conclusion






















































Fatemeh Kazemi-Lomedasht is a highly qualified candidate for the Best Researcher Award, given her impressive research background, significant publications, and innovative contributions to biotechnology. Her strengths in cancer research and monoclonal antibodies are notable, and her role as an Associate Professor underscores her leadership in the field. Addressing areas for improvement, such as broadening the impact of her work and enhancing interdisciplinary collaboration, could further elevate her candidacy. Overall, her achievements and contributions make her a strong contender for this award.


















Publications Top Notes


    

  • “Single-domain antibodies or nanobodies: a class of next-generation antibodies”

      

    • Authors: F Khodabakhsh, M Behdani, A Rami, F Kazemi-Lomedasht
      • 

    • Journal: International Reviews of Immunology
      • 

    • Year: 2018
      • 

    • Citations: 101
      • 

    

    • 

  • “Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody”

      

    • Authors: F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, …
      • 

    • Journal: Molecular Immunology
      • 

    • Year: 2015
      • 

    • Citations: 82
      • 

    

    • 

  • “Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer”

      

    • Authors: A Rami, N Zarghami
      • 

    • Journal: Advanced Pharmaceutical Bulletin
      • 

    • Year: 2013
      • 

    • Citations: 76
      • 

    

    • 

  • “Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs”

      

    • Authors: E Karami, M Behdani, F Kazemi-Lomedasht
      • 

    • Journal: Journal of Drug Delivery Science and Technology
      • 

    • Year: 2020
      • 

    • Citations: 74
      • 

    

    • 

  • “An overview on application of phage display technique in immunological studies”

      

    • Authors: A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, …
      • 

    • Journal: Asian Pacific Journal of Tropical Biomedicine
      • 

    • Year: 2017
      • 

    • Citations: 67
      • 

    

    • 

  • “The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus”

      

    • Authors: F Kazemi-Lomedasht, V Khalaj, KP Bagheri, M Behdani, …
      • 

    • Journal: Toxicon
      • 

    • Year: 2017
      • 

    • Citations: 47
      • 

    

    • 

  • “Nanobodies as novel therapeutic agents in envenomation”

      

    • Authors: E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, …
      • 

    • Journal: Biochemical and Biophysical Journal (BBA)-General Subjects
      • 

    • Year: 2018
      • 

    • Citations: 42
      • 

    

    • 

  • “Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)”

      

    • Authors: V Homayouni, M Ganjalikhani-Hakemi, A Rezaei, H Khanahmad, …
      • 

    • Journal: Iranian Journal of Basic Medical Sciences
      • 

    • Year: 2016
      • 

    • Citations: 41
      • 

    

    • 

  • “Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization”

      

    • Authors: A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, …
      • 

    • Journal: Drug Testing and Analysis
      • 

    • Year: 2020
      • 

    • Citations: 33
      • 

    

    • 

  • “Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function”

      

    • Authors: F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani
      • 

    • Journal: Iranian Journal of Basic Medical Sciences
      • 

    • Year: 2018
      • 

    • Citations: 33
      • 

    

    •